Home

Glaxosmithkline Pharmaceuticals Ltd PE Ratio

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

PE

54.3

Last updated on: Apr 04, 2025

Key Highlights

  • The P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd is 54.3 as of 04 Apr 15:30 PM .
  • The P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd changed from 226.4 on March 2020 to 55.8 on March 2024 . This represents a CAGR of -24.43% over 5 years.
  • The Latest Trading Price of Glaxosmithkline Pharmaceuticals Ltd is ₹ 2735 as of 04 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd

No data available

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

Share Price

₹ 2735.75

-122.15 (-4.27%)

stock direction

Last updated on: Apr 04, 2025

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Apr 20252735.75
03 Apr 20252857.9
02 Apr 20252776.6
01 Apr 20252793.4
28 Mar 20252877.3
27 Mar 20252836.6
26 Mar 20252820.4
25 Mar 20252834.7
24 Mar 20252882.9
21 Mar 20252943.6

SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Glaxosmithkline Pharmaceuticals Ltd46345
Sun Pharmaceutical Industries Ltd410142
Divis Laboratories Ltd145762
Cipla Ltd114322
Torrent Pharmaceuticals Ltd111166
Mankind Pharma Ltd101098

PE Ratio of Glaxosmithkline Pharmaceuticals Ltd Explained

46345

Market cap

859

Earnings

54.3X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Glaxosmithkline Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in %

About Glaxosmithkline Pharmaceuticals Ltd

  • GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together.
  • The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra, 22 contract manufacturing organisations (CMOs) with regional and sales hubs across India.
  • The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. The Company's portfolio includes General Medicines, Vaccines and Specialty medicines that help prevent and treat disease.
  • Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases.

Glaxosmithkline Pharmaceuticals Ltd News Hub

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju

Read more

05 Aug 24

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju

Read more

03 Aug 24

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O

Read more

25 Oct 24

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting

Read more

29 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Glaxosmithkline Pharmaceuticals Ltd

What is the current PE Ratio of Glaxosmithkline Pharmaceuticals Ltd?

The Current PE Ratio of Glaxosmithkline Pharmaceuticals Ltd is 54.26 as on 4 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 4 Apr 2025.

What was the PE Ratio of Glaxosmithkline Pharmaceuticals Ltd last year?

The PE Ratio of Glaxosmithkline Pharmaceuticals Ltd was 36.73 last year, now the PE ratio is 54.26, showing a year-on-year growth of 47.7%.

What does the PE Ratio of Glaxosmithkline Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Glaxosmithkline Pharmaceuticals Ltd is 54.26. This ratio indicates that investors are willing to pay 54.26 times the earnings per share for each share of Glaxosmithkline Pharmaceuticals Ltd.

What is the PE Ratio Growth of Glaxosmithkline Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Glaxosmithkline Pharmaceuticals Ltd grew by 47.7% whereas, the EPS ratio grew by -7.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions